The UK health regulator said this morning it has approved Ronapreve, the antibody developed by Roche and Regeneron, to prevent and treat Covid-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) said the approval was the first in the UK for a monoclonal antibody treatment for the disease caused by the coronavirus.
In July, Japan became the first country to licence the drug, which a lab trial found lowered hospitalisation or mortality by 70% and lessened the symptom period by four days.
Other countries followed suit and Ronapreve is now licenced in places such as the US, India, Switzerland, Canada and the EU.
Source The Guardian
